Discovery of the first dual GSK3ß inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease. (2017)

First Author: Gameiro I
Attributed to:  The Spatiotemporal Regulation of the Keap1/Nrf2 pathway funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/srep45701

PubMed Identifier: 28361919

Publication URI: http://europepmc.org/abstract/MED/28361919

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

ISSN: 2045-2322